Detalles de la búsqueda
1.
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group.
Biol Blood Marrow Transplant;
25(5): 932-940, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30579966
2.
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel.
Blood;
129(13): 1753-1762, 2017 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-28096091
3.
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey.
Clin Infect Dis;
65(11): 1884-1896, 2017 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-29020286
4.
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R.
Blood;
123(15): 2333-42, 2014 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24558201
5.
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol;
16(15): 1525-1536, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26429297
6.
Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma.
Am J Hematol;
90(3): 230-4, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25502635
7.
Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant;
19(8): 1244-53, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23756210
8.
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome.
Am J Hematol;
88(7): 581-8, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23606215
9.
Infection and coinfection of human rhinovirus C in stem cell transplant recipients.
Clin Dev Immunol;
2013: 236081, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23533453
10.
Epidemiological, molecular and clinical features of enterovirus 109 infection in children and in adult stem cell transplant recipients.
Virol J;
9: 183, 2012 Sep 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-22947270
11.
Differential outcome of neurological HCMV infection in two hematopoietic stem cell transplant recipients.
BMC Infect Dis;
12: 238, 2012 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-23031364
12.
Human Cytomegalovirus-Specific T-Cell Reconstitution and Late-Onset Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation Recipients following Letermovir Prophylaxis.
Transplant Cell Ther;
28(4): 211.e1-211.e9, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35042012
13.
Early T cell reconstitution and cytokine profile may help to guide a personalized management of human cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
J Clin Virol;
135: 104734, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33476929
14.
Molecular epidemiology of KI and WU polyomaviruses in infants with acute respiratory disease and in adult hematopoietic stem cell transplant recipients.
J Med Virol;
82(1): 153-6, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19950241
15.
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Blood;
112(3): 895-902, 2008 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18497321
16.
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study.
Haematologica;
95(3): 476-84, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19903678
17.
Pretransplantation therapy with hypomethylating agents in patients with myelodysplastic syndromes receiving reduced-intensity conditioning regimens.
Biol Blood Marrow Transplant;
20(9): 1260-1, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25020100
18.
Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Haematologica;
93(2): 248-56, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18245650
19.
Neurological Complications Involving the Central Nervous System After Allogeneic Hematopoietic Stem Cell Transplantation During a Period of Evolution in Transplant Modalities: A Cohort Analysis.
Transplantation;
101(3): 616-623, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27222935
20.
Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo Osseo.
Am J Hematol;
86(10): 897-902, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21809371